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Introduction: Patients with heart failure have a significant symptom burden and
other palliative care needs often over a longer period than patients with cancer. It is
acknowledged that this need may be unmet but by how much has not been
quantified in primary care data at the population level.
Methods: This was the first use of Clinical Practice Research Datalink, the world’s
largest primary care database to explore recognition of the need for palliative care.
Heart failure and cancer patients who had died in 2009 aged 18 or over and had at
least one year of primary care records were identified. A palliative approach to care
among patients with heart failure was compared to that among patients with cancer
using entry onto a palliative care register as a marker for a palliative approach to
care.
Results: Among patients with heart failure, 7% (234/3 122) were entered on the
palliative care register compared to 48% (3 669/7 608) of cancer patients. Of heart
failure patients on the palliative care register, 29% (69/234) were entered onto the
register within a week of their death.
Conclusions: This confirms that the stark inequity in recognition of palliative care
needs for people with heart failure in a large primary care dataset. We recommend
a move away from prognosis based criteria for palliative care towards a patient
centred approach, with assessment of and attention to palliative needs including
advance care planning throughout the disease trajectory.
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Introduction
Early palliative care in cancer consistently leads to better patient and caregiver
outcomes [1]. These include improvement in symptoms, quality of life, patient
satisfaction, reduced caregiver burden and healthcare costs [2]. Patients with
advanced chronic heart failure (CHF) have a significant symptom burden and a
range of palliative care needs [3] often over a longer period than patients with
cancer [4]. Qualitative studies [3], audits [5, 6] and analysis of data from specialist
palliative care services [7], however, suggest unmet palliative care need. Prognosis
is variable, both within and between populations and may be difficult to predict in
an individual patient [8–10].
Position statements from Europe, the United States and Canada agree on the
importance of providing a palliative care approach and access to specialist palliative
care services for people with heart failure [11–13]. Policy initiatives focus on
prognosis based criteria such as recognition that the patient is likely to be in the last
year of life as the first step in a co-ordinated transition to a palliative approach to
care. This approach aims to maximise quality of life by early assessment and
addressing of palliative care needs, identifying and supporting patient preferences
for care and proactive care planning [14, 15]. The Quality and Outcomes
Framework (QOF) is a voluntary incentive scheme for family physicians in the UK
[16]. Since 2006 QOF has encouraged primary care to form a practice-based register
of all patients, regardless of underlying diagnosis, requiring a palliative approach
and to hold multidisciplinary meetings to co-ordinate their care and is used by over
99% of primary care practices in the UK [17]. Separate QOF registers are also held
for cancer and heart failure [17]. Family physicians play an important role in
palliative care, in most countries, providing care themselves and referring to
specialist services and are therefore pivotal to early recognition of palliative care
need [18]. In England, palliative care is provided by family physicians and their
teams, who can also refer to specialist palliative care services. Specialist palliative
care services are available for all life limiting conditions, not just cancer [15].
To the authors’ knowledge, this is the first time a national primary care
database has been used to investigate if there is any inequity and if present
quantify the degree of inequity country-wide with regard to recognition of the
need for a palliative approach and to explore the timing of such recognition in
relation to the patient’ death.
The aim of this study was to explore whether people with CHF are identified as
needing a palliative care approach, as marked by entry on the QOF palliative care
register and when, in relation to the time of death, this occurred.
Methods
Data source
Clinical Practice Research Datalink (CPRD), (previously the General Practice
Research Database (GPRD)) is a well-validated database of anonymised electronic
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contemporaneous medical records from primary care in the UK [19]. It is the
world’s largest source of anonymous longitudinal data from primary care [20].
Data from five million persons are included in CPRD and demographically it is
representative of the UK population as a whole [21]. In the UK the estimated mid
2009 UK population was 62 million [22] and so CPRD represents about 8% of the
UK population. Clinical information is recorded in Read codes (coded thesaurus
of clinical terms widely used in the NHS especially in primary care).
Population
We defined the study population as patients that: were registered with a primary
care practice that contributes to CPRD database in England; who had died during
2009; were over 18 at the time of their death and had a minimum of one year follow-
up records in the database prior to their death that met CPRD acceptability criteria
for the quality of data entered. The patient groups (diagnosis of cancer or heart
failure) and patients registered as needing a palliative approach to care are QOF
indicators and they therefore have defined criteria and Read codes (see table 1 and
Table S1 and S2 in File S1). Co-morbidities: diabetes mellitus, stroke, chronic
kidney disease and chronic obstructive pulmonary disease were also QOF indicators
(see Table S3 to S5 in File S1). Diseases included on QOF registers are selected on
the basis that they are able to be clearly defined and diagnosed [23–25]. The data
from QOF is being used to calculate prevalence data for chronic disease burden in
the population and so are robust methods of identifying a disease [26].
Registration on the palliative care register is used as a proxy measure that a
palliative approach to care has been recognised.
Data analysis
The Read codes were translated into medcodes, the coding system used in CPRD
and patients divided into: ‘‘heart failure only’’; ‘‘cancer only’’; ‘‘heart failure and
cancer’’ based on if they were coded as being diagnosed with heart failure or
cancer or not at any time prior to death. We extracted the following data: number
of patients in each group; number on the palliative care register; time from
registration to death; sex. As month of birth is not provided in CPRD, age at death
was calculated as from 2009 (year of death) minus the year of birth. Loop diuretic
prescriptions were identified using the productcode variable which links to British
National Formulary (BNF) chapter headings and so all loop diuretic prescriptions,
including combination preparations were identified.
Sensitivity analyses were carried out to determine the effect of only including
more recently recorded (within one year and five years of death) heart failure or
cancer codes in the analysis as conditions diagnosed in the past may not have
contributed to the patient’s death. This was performed for all cases and cases
where the patient was on the palliative care register. Data is summarised using
descriptive statistics, reported as absolute numbers and proportions. The time in
days from first recording of clinical code to date of death is presented as median
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and interquartile ranges and age as mean and standard deviation. Differences in
the distributions by age, sex and timing of condition among those on the palliative
care register and the total number of patients were tested using Pearson’s chi
squared. Analyses were conducted using Stata version 12.1.
Ethical approval
The CPRD Group has obtained ethical approval from a National Research Ethics
Service Committee (NRES) for all purely observational research using
anonymised CPRD data. This study was approved by the Independent Scientific
Advisory Committee (ISAC) for Medicines and Healthcare products Regulatory
Agency (MHRA) database research permission (Protocol number: 10_168R). No
further ethics approval was required for the analysis of the data as it was purely
observational research using anonymised CPRD data.
Results
A total of 31 667 adult patients in the CPRD database were recorded as having
died in 2009 and of these patients 27 689 (87%) had sufficiently complete records
Table 1. The QOF criteria and Read codes for: patients identified as needing a palliative care approach, heart failure and cancer.
Disease or health




Clinician predicted survival of less than a year. A
positive response to the question–‘would I be
surprised if this patient were still alive in 12 months?’
Patients with advanced or irreversible disease and clinical
indicators of progressive deterioration such







7060; 6664; 6924;12739; 18551;
10019; 9755; 74909; 26353; 22288;
26354; 49651; 100607; 100525;
Heart failure Heart failure is a complex clinical syndrome of
symptoms and signs that suggest impairment of the
heart as a pump supporting physiological circulation.
It is caused by structural or functional abnormalities of
the heart. The demonstration of objective evidence of
these cardiac abnormalities is necessary for the
diagnosis of heart failure to be made.$ All patients
with suspected heart failure should be investigated
and this is expected to involve, specialist investigation
(such as echocardiography and/or natiuretic peptide
assay) and often specialist opinion. All heart failure
patients, including those with heart failure with
preserved ejection fraction should be included.*
G581.%; 585f.; 585g.;
G5yy9; G5yyA
398; 884; 2062; 2906; 4024; 1223;
5942; 13189; 18853; 19066; 5255;
32671; 10079; 9524; 17278; 10154;
23707; 27964; 23481; 27884; 51214;
11424; 22262; 43618; 12590; 94870;
101138; 101137
Cancer All patients with a diagnosis of cancer excluding
non-melanoma skin cancers.
B0… - B32z.; B34..
-B6z0.; Byu.. - Byu41;
Byu5. - ByuE0
#
$National Clinical Guideline Centre for Acute and Chronic Conditions. NICE Clinical Guideline No 108: CHRONIC HEART FAILURE: National clinical
guideline for diagnosis and management in primary and secondary care. London: National Clinical Guideline Centre; 2010.
*As the therapeutic and prognostic benefits of therapy are only proven in those with reduced ejection fraction heart failure, patients with heart failure with
preserved ejection fraction may be under represented in heart failure QOF registers.
#Available as a Table S1 in File S1.
doi:10.1371/journal.pone.0113188.t001
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to meet the eligibility criteria of at least one year of up to standard records. Of
these, 48% were men and the group’s mean age was 78 years (standard deviation
14 years). The median year of recording of first clinical information in a record
was 1972 (interquartile range 1957 to 1988). 5 311/27 689 (19%) of patients were
entered onto the palliative care register prior to their death.
2 811 (90%) of the 3 122 patients with heart failure were recorded as being
prescribed loop diuretic therapy. Some loop diuretic prescribing such as those
from hospital clinics is not recorded on CPRD. These are unlikely to be many, and
would relate to single short periods of prescription as it is unusual for secondary
care to take responsibility for on-going diuretic prescription.
Looking at comorbidities of the 27 689 patients 4 740 (17%) had diabetes
mellitus, 5050 (18%) had a stroke, 7 537 (27%) had chronic kidney disease and 3
678 (13%) had chronic obstructive pulmonary disease. The heart failure group of
3 122 patients 812 (26%) had diabetes mellitus, 741 (24%) had a stroke, 15 58
(50%) had chronic kidney disease and 603 (19%) had chronic obstructive
pulmonary disease. Chronic kidney disease is defined as stage three to five chronic
kidney disease, estimated glomerular filtration rate of less than 60 mL/min.
The number of patients by disease register, and the numbers of each also on the
palliative care register can be seen in (table 2). Comparison of the total
population with those on the palliative care register showed cancer patients on the
palliative care register tended to be younger than the total but there is no
suggestion of age difference among the heart failure patients. There was a marked
difference in the percentage of patients on the heart failure or cancer registers who
were also on the palliative care register 7% and 48% respectively.
Sensitivity analyses
Sensitivity analyses were carried out for the heart failure only and the cancer only
groups. The proportions of heart failure patients on the palliative care register
with the one year and five year sensitivity analysis were 46/718 (6%) and 113/1
545 (7%) respectively and very similar to the proportion without the sensitivity
analysis at 234/3 122 (7%). In the cancer only group the proportion of patients on
the palliative care register with the one year and five year sensitivity analysis were
similar at 1 535/2 932 (52%) and 2 931/5 382 (54%) but higher than the
proportion without sensitivity analysis which was 3 669/7 608 (48%).
Timing of entry onto palliative care register prior to death
The time from entry onto the palliative care register to the time of death by each
diagnosis can be seen in table 3. Of those entered onto the palliative care register,
the vast majority of both cancer register and heart failure register groups (79%
and 80%) had been entered during the last year of life. Again, in both groups a
similar proportion (11% and 8% respectively) had been on the palliative care
register for over two years. However, in the heart failure group, a third of patients
were not entered onto the palliative care register until the week prior to their
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death and nearly a half only in the six weeks prior to their death. This contrasts
with the cancer patients where only 8% were registered in the week prior to their
death, and 29% in the 6 weeks prior to death. The late registration of heart failure
patients onto the palliative care register is not explained by late diagnosis of heart
failure compared to cancer (table 2). Regardless of when the heart failure
diagnosis was recorded the proportion on the palliative care register was the same.
Table 2. Proportion of patients, with each diagnosis, identified as being on the palliative care register; demographic data (age, sex) and time from diagnosis
recorded until death. Percentages may not total 100 due to rounding.














register; N (% of
Total)
Total 3 122 (100) 234 (7) 7 608 (100) 3 669 (48) 803 (100) 257 (32)
Sex
Male 1 462 (47) 110 (47) 3 922 (52) 1 901 (52) 448 (56) 158 (61)
Female 1 660 (53) 124 (53) 3 686 (48) 1 768 (48) 355 (44) 99 (39)
Pearson’s x2;
p-value




,60 87 (3) 7 (3) 854 (11) 550 (15) 11 (1) 6 (3)
60 to 69 202 (6) 14 (6) 1 492 (20) 872 (24) 57 (7) 24 (9)
70 to 79 598 (19) 44 (19) 2 173 (29) 1 114 (30) 190 (24) 74 (29)
80 to 89 1 382 (44) 111 (47) 2 389 (31) 957 (26) 396 (49) 120 (47)
>90 853 (27) 58 (25) 700 (9) 176 (5) 149 (19) 33 (13)
Pearson’s x2;
p-value






#1 week 231 (7) 7 (3) 260 (3) 69 (2) 19 (2) 8 (3)
.1 week to 6 weeks 94 (3) 9 (4) 541 (7) 224 (6) 57 (7) 22 (9)
.6 weeks to 6
months
206 (7) 13 (6) 1 282 (17) 705 (19) 128 (16) 53 (21)
.6 months to 1
year
187 (6) 17 (7) 849 (11) 537 (15) 77 (10) 30 (12)
.1 year to 2 years 235 (8) 19 (8) 1 093 (14) 686 (19) 101 (13) 37 (14)
.2 years to 5 years 592 (19) 48 (21) 1 357 (18) 710 (19) 198 (25) 66(26)
.5 years 1 455 (47) 117 (50) 2 109 (28) 706 (19) 219(27) 41(16)
Missing 122 (4) 4 (2) 117 (2) 32 (1) 4 (0.5) 0
Pearson’s x2; p-
value
x2511.1 p50.13 x25168.0 p,0.01 x2516.3 p50.02
doi:10.1371/journal.pone.0113188.t002
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Discussion
These data show a marked difference between the proportion of heart failure
patients (7%) on the palliative care register and that of cancer patients (48%) in a
sample representative of national data. Furthermore, patients with heart failure
that are entered on the palliative care register are entered much later than those
with cancer. Although we present a proxy marker for recognition of the need for a
palliative care approach which is specific to the UK health care system, the
problem illustrated is likely to one that is familiar in different settings. Barriers to
the provision of palliative care for people living with heart failure are described
well in the literature [3] [12, 27]. Clinicians are often reluctant to discuss poor
prognosis of people with heart failure because of its unpredictable course,
concerned they may cause premature alarm and destroy hope. Consequently,
these conversations rarely take place [3]. This has been termed ‘‘prognostic
paralysis’’ and our findings are consistent with this observation [28].
Our data are similar to English primary care audit data [5] and practice based
data, albeit from a smaller study [6]. Data from a Danish primary care population
is consistent with increased likelihood of recognition of the need for a palliative
approach in cancer patients compared to those with a non-cancer condition; only
4% of chronic obstructive pulmonary disease patients received the free medication
provided for those with a terminal illness compared with 55% of patients with
lung cancer who died [29].
Our study had the strength of a very large population-based sample drawn from
primary care throughout England [19]. The system of health care in the UK is
such that the 99% of the population are registered with a family physician [26].
The use of routinely collected data has the advantage that it was not collected for
the study, so is representative of actual practice and was not biased by knowledge
of the study, especially as it was unselected for the factors of interest. The main
search terms are well-defined by QOF thus increasing the confidence that the
Table 3. Time and summary statistics in days (median and interquartile 25 to 75% range) from first time coded as on a palliative care register to date of death
for each disease group.
Time between palliative care register and
death Total (%) Heart failure only N (%) Cancer only; N (%)
Heart failure and cancer; N
(%)
Total 5 311 (100) 234 (100) 3 669(100) 257 (100)
Median (interquartile range) 95 (24–289) 63 (5–220) 115.5 (36–311) 99.5 (28.5–382)
#1 week 692 (13) 69 (29) 294 (8) 30 (12)
.1 week to 6 weeks 1 113 (21) 40 (17) 755 (21) 61 (24)
.6 weeks to 6 months 1 594 (30) 57 (24) 1 193 (33) 60 (23)
,6 months to 1 year 838 (16) 24 (10) 640 (17) 37 (14)
,1 year to 2 years 664 (12) 17 (7) 504 (14) 32 (12)
.2 years 396 (7) 26 (11) 276 (8) 36 (14)
Missing 14 (0.3) 1 (0.4) 7 (0.2) 1 (0.4)
Percentages may not total 100 due to rounding.
doi:10.1371/journal.pone.0113188.t003
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recording is accurate, and likely to be complete or near complete by family
physicians. Ninety per cent of the heart failure decedents were prescribed loop
diuretics. The QOF also encouraged prescribing of an ACE inhibitor or
Angiotensin Receptor Blocker to 40 to 80% of patients on the register, which was
achieved by 97.7% of practices in 2009. Additional prescribing of a B-blocker to
40 to 60% of patients on the register was achieved by 96.1% of practices [30].
Heart failure has a variable disease trajectory and sudden death may occur.
From the data recorded in CPRD it is not possible to identify which deaths were
sudden. It is estimated that each GP caseload in the UK has about 20 deaths (all
cause) per year, but only one or two of these deaths are sudden.(10) Another
source suggests that about a quarter of deaths are sudden.(3) These sudden deaths
are due to all causes, not just heart failure patients. However if we over-estimated
the number of sudden deaths as a quarter of heart failure deaths, and exclude
from the analysis, this would still mean that only 10% (234/2341.5) of heart
failure patients were recognised as needing palliative care prior to their death.
About 20 per cent of patients were on the palliative care register for more than a
year. Some practices may use a problem based approach to palliative care and so
have patients who are not in the last year of life or alternatively it could be due to
difficulty in accurately predicting the last year of life.
Limitations
Registration on the palliative care QOF is a proxy measure for clinical recognition
of the need for a palliative approach to care and it may be less useful in palliative
care for people with non-malignant conditions. Despite clear policy guidance,
there may be a perception that the palliative care QOF is for cancer patients only
and that those with other conditions do not need this approach. However, if so,
this in itself is an inequity. Identification is only the first step of a palliative care
approach. As we used in-life diagnosis data rather than cause of death data, such
as death certification, our denominator may be overestimated. However, death
certificates may be inaccurate and may fail to record the contribution of an
underlying condition such as cancer or heart failure [31]. Our sensitivity analyses
using diagnoses within a year and five years of death did not indicate that this was
a major problem for heart failure. For cancer there was a higher percentage in the
sensitivity analysis indicating that the proportion of cancer patients identified as
needing a palliative care approach may be higher than reported and the inequity
between the two groups, may be wider. In addition, central death certificate data
from all deaths registered in England during 2009, the same year as this study,
showed the proportions dying from chronic coronary heart disease (14% deaths)
and cancer (29% deaths) are similar to this CPRD study.
Implications for practice, policy or future research
We report the first use, to our knowledge, of the world’s largest primary care
database using nationally representative data to quantify the recognition of the
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need for a palliative approach to care and its timing in relation to death. This
method could be used to explore other progressive life limiting illnesses such as
chronic obstructive airway disease and dementia.
Recognition of the need for a palliative approach to care tends to be done much
later in the disease trajectory in those with heart failure. Nearly one in three heart
failure patients in our dataset were first registered within a week of death. This is a
time when inevitable and irreversible deterioration is more apparent, but may be
more difficult to ascertain a patient’s wishes during such rapid deterioration.
A palliative care approach can and should run in parallel with optimal heart
failure management [11, 12]. Awareness for clinicians and patients of an approach
which can incorporate palliative care as needed from diagnosis and throughout
the disease trajectory will prevent the difficulties of an all or none transition point
or the prognostic paralysis that occurs when ‘‘the right time’’ becomes the
primary focus [12, 27, 32]. As with cancer, many people with heart failure do wish
to discuss end-of-life issues [3] and guidance and training have been developed
that allow for discussions about poor prognosis and decisions about future care
despite uncertain disease trajectories [27].
Prognostication regarding the last year of life is heart failure is very difficult. The
Gold Standards Framework-Prognostic Indicator Guide [33], recommended as a
tool to predict which patients should be on the QOF palliative care register, but has
no published data to support its accuracy [34]. A recent study has shown that neither
the Gold Standards Framework-Prognostic Indicator Guide or the Seattle Heart
Failure Model (an extensively validated tool, considered ‘gold standard’ for routine
prognostication in ambulant heart failure populations [34]) were useful in accurately
predicting the last year of life in a group of community heart failure patients in the
UK [33]. We suggest that future research regarding identification of patients for a
palliative care approach for patients with heart failure should focus on patients’
problems rather than prognosis. This will allow amore patient centred approach that
can facilitate conversations about future even if that future is not yet certain.
After more than a decade of national policy recommending a palliative care for
patients with heart failure, the stark finding of this large UK primary care database
study was that people with heart failure are relatively absent from the recommended
primary care system for co-ordinating palliative care. This has implications for
individuals and their families. It also has the globally applicable lesson to move away
from a prognosis based criteria for palliative care which discriminate against
progressive, life limiting illnesses with an uncertain prognosis. We recommend
patient centred approaches that include an integrated approach to palliative care
provision in heart failure, with assessment of and attention to palliative needs
including advance care planning throughout the disease trajectory.
Supporting Information
File S1. Contains the following files: Table S1. Medcodes for being on the cancer
register. Table S2. Medcodes for being on the heart failure register. Table S3.
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Medcodes for being on the diabetes register. Table S4. Medcodes for being on the
stroke register. Table S5. Medcodes for being on the COPD register.
doi:10.1371/journal.pone.0113188.s001 (DOCX)
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